StockData

Insmed vs United Therapeutics

INSM and UTHR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How INSM and UTHR compare

Insmed and United Therapeutics are about the same size, with market caps of $26.7B and $25.1B.

Insmed grew revenue faster over the last twelve months (240% versus 2.5% for United Therapeutics).

United Therapeutics keeps more of each dollar of sales as profit, with a net margin of 41.6% compared with −39.9% at Insmed.

United Therapeutics scores higher on the StockData Score (11 against 8 for Insmed), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricINSMUTHR
Size and price
Market cap$26.7B$25.1B
Share price$121.86$584.10
Change, 1 year−36.9%25.2%
Change, 5 years321%202%
Beta (5Y)0.840.45
Employees1,6641,400
StockData Score
Total score811 (better)
Valuation score01 (better)
Growth score3 (better)2
Performance score25 (better)
Health score33
Dividend score00
Valuation
P/E–20.9×
P/S17.6×7.9× (better)
P/B36.8×3.9× (better)
EV/EBITDA–15.0×
P/FCF–22.9×
PEG–0.91
FCF yield−2.3%4.4% (better)
Fair value$61.10$479.23
Margin of safety−99.5%−21.9% (better)
Growth
Revenue growth (TTM)240% (better)2.5%
Revenue growth, 5Y average29.8% (better)16.5%
Net income growth (TTM)–5.5%
EPS growth (TTM)–9.0%
EPS growth, 5Y average–19.3%
Profitability
Gross margin84.4%86.1% (better)
Operating margin−37.1%44.4% (better)
Net margin−39.9%41.6% (better)
FCF margin−41.3%34.6% (better)
Return on equity−72.5%19.3% (better)
Return on invested capital–29.7%
Financial health
Debt / equity0.76–
Interest coverage−6.9×117× (better)
Current ratio2.865.73 (better)
Altman Z-score7.4221.67 (better)
Piotroski F-score48 (better)
Dividends and buybacks
Buyback yield–10.0%
Shareholder yield0.00%10.0% (better)
Ownership
Held by institutions102%97.4%
Held by insiders0.89%9.1%
Insider net buying, 12 months−$133M (better)−$1.4B
Superinvestors holding1–
Short interest, % of float6.5%4.7%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.